Marie Thibault
Stock Analyst at BTIG
(3.97)
# 568
Out of 5,090 analysts
101
Total ratings
55.91%
Success rate
9.78%
Average return
Main Sectors:
Stocks Rated by Marie Thibault
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EW Edwards Lifesciences | Maintains: Buy | $100 → $103 | $86.19 | +19.50% | 2 | Dec 5, 2025 | |
| MASI Masimo | Maintains: Buy | $198 → $200 | $141.68 | +41.16% | 7 | Dec 4, 2025 | |
| HAE Haemonetics | Reiterates: Buy | $88 | $83.94 | +4.84% | 3 | Nov 21, 2025 | |
| BSX Boston Scientific | Reiterates: Buy | $132 | $97.52 | +35.36% | 14 | Nov 21, 2025 | |
| PODD Insulet | Maintains: Buy | $370 → $380 | $304.49 | +24.80% | 6 | Nov 21, 2025 | |
| ABT Abbott Laboratories | Reiterates: Buy | $145 | $125.08 | +15.93% | 14 | Nov 20, 2025 | |
| KMTS Kestra Medical Technologies | Initiates: Buy | $32 | $24.07 | +32.95% | 1 | Nov 18, 2025 | |
| OM Outset Medical | Maintains: Buy | $39 → $17 | $4.39 | +287.24% | 1 | Nov 11, 2025 | |
| ARAY Accuray | Maintains: Buy | $5 → $4 | $0.99 | +305.89% | 2 | Nov 6, 2025 | |
| DCTH Delcath Systems | Reiterates: Buy | $23 | $9.78 | +135.17% | 4 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $109 → $85 | $65.49 | +29.79% | 8 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $215 | $178.37 | +20.54% | 8 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.16 | - | 1 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $11.69 | +113.86% | 3 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.40 | - | 2 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $58 → $52 | $39.86 | +30.46% | 7 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $62 → $65 | $70.79 | -8.18% | 8 | Oct 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.15 | - | 2 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.93 | - | 3 | Oct 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.35 | - | 3 | Oct 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.62 | - | 1 | Jan 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $6 | $352.05 | -98.30% | 1 | Apr 9, 2020 |
Edwards Lifesciences
Dec 5, 2025
Maintains: Buy
Price Target: $100 → $103
Current: $86.19
Upside: +19.50%
Masimo
Dec 4, 2025
Maintains: Buy
Price Target: $198 → $200
Current: $141.68
Upside: +41.16%
Haemonetics
Nov 21, 2025
Reiterates: Buy
Price Target: $88
Current: $83.94
Upside: +4.84%
Boston Scientific
Nov 21, 2025
Reiterates: Buy
Price Target: $132
Current: $97.52
Upside: +35.36%
Insulet
Nov 21, 2025
Maintains: Buy
Price Target: $370 → $380
Current: $304.49
Upside: +24.80%
Abbott Laboratories
Nov 20, 2025
Reiterates: Buy
Price Target: $145
Current: $125.08
Upside: +15.93%
Kestra Medical Technologies
Nov 18, 2025
Initiates: Buy
Price Target: $32
Current: $24.07
Upside: +32.95%
Outset Medical
Nov 11, 2025
Maintains: Buy
Price Target: $39 → $17
Current: $4.39
Upside: +287.24%
Accuray
Nov 6, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $0.99
Upside: +305.89%
Delcath Systems
Nov 4, 2025
Reiterates: Buy
Price Target: $23
Current: $9.78
Upside: +135.17%
Oct 31, 2025
Maintains: Buy
Price Target: $109 → $85
Current: $65.49
Upside: +29.79%
Oct 31, 2025
Maintains: Buy
Price Target: $195 → $215
Current: $178.37
Upside: +20.54%
Oct 20, 2025
Downgrades: Neutral
Price Target: n/a
Current: $2.16
Upside: -
Sep 5, 2025
Reiterates: Buy
Price Target: $25
Current: $11.69
Upside: +113.86%
Aug 20, 2025
Downgrades: Neutral
Price Target: n/a
Current: $4.40
Upside: -
Apr 30, 2025
Maintains: Buy
Price Target: $58 → $52
Current: $39.86
Upside: +30.46%
Oct 14, 2024
Maintains: Buy
Price Target: $62 → $65
Current: $70.79
Upside: -8.18%
Jun 25, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.15
Upside: -
Oct 6, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.93
Upside: -
Oct 13, 2021
Downgrades: Neutral
Price Target: n/a
Current: $1.35
Upside: -
Jan 21, 2021
Downgrades: Neutral
Price Target: n/a
Current: $6.62
Upside: -
Apr 9, 2020
Maintains: Buy
Price Target: $11 → $6
Current: $352.05
Upside: -98.30%